ltc004
Small moleculeexperimental
Clinical trial activity
7 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2022 (NCT05666635)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06490068 | Phase 2 | Jun 4, 2024 | Chinese Academy of Medical Sciences |
| NCT06384248 | Phase 1/Phase 2 (Phase 2) | Apr 26, 2024 | Letolab |
| NCT06384235 | Phase 1/Phase 2 (Phase 2) | Apr 25, 2024 | Letolab |
| NCT06322563 | Phase 2 | Apr 1, 2024 | Tianjin Medical University |
| NCT06255912 | Phase 2 | Mar 1, 2024 | Chinese Academy of Medical Sciences |
| NCT06277804 | Phase 1 | Mar 1, 2024 | Letolab |
| NCT05666635 | Phase 1 | Dec 31, 2022 | Letolab |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Letolab | For profit | 4 | 4 | 2 | 2022 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Tianjin Medical University | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1